SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

11118	Companies
244805	Keywords
172884	Articles
131993	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 10/20/2025 at 08:30, 11 months 14 days ago

Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
New phase 2 data presented at ESMO Congress highlight AlphaMedix as a promising targeted alpha therapy for GEP-NETs, showing high response rates and potential to address unmet medical needs

ESMO Congress AlphaMedix Phase 2 Data GEP-NETs Targeted Alpha Therapy
BRIEF

published on 10/20/2025 at 07:05, 11 months 14 days ago

Sanofi's High-Dose Flu Vaccine Shows Enhanced Protection for Seniors

Sanofi Flu Vaccine Senior Health Hospitalization Reduction FLUNITY-HD Study
PRESS RELEASE

published on 10/20/2025 at 07:00, 11 months 14 days ago

Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose
Sanofi's high-dose influenza vaccine Efluelda/Fluzone High-Dose shows superior protection for older adults by reducing hospitalizations. FLUNITY-HD study details robust evidence published in The Lancet

Older Adults Sanofi Influenza Vaccine FLUNITY-HD Study Hospitalizations
BRIEF

published on 10/17/2025 at 13:10, 11 months 17 days ago

Sanofi's Wayrilz recommended by CHMP for IPT

Sanofi CHMP BTK Inhibitor Wayrilz Immune Thrombocytopenia
PRESS RELEASE

published on 10/17/2025 at 13:05, 11 months 17 days ago

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
CHMP recommends Sanofi's Wayrilz for EU approval to treat immune thrombocytopenia, targeting disease root cause through multi-immune modulation. Positive phase 3 study results showcased rapid platelet response and symptom improvements

Sanofi CHMP Wayrilz Immune Thrombocytopenia Multi-immune Modulation
BRIEF

published on 10/17/2025 at 13:05, 11 months 17 days ago

Sanofi faces negative EU opinion on Rezurock

Europe Sanofi CHMP Rezurock CGVHD
PRESS RELEASE

published on 10/17/2025 at 13:00, 11 months 17 days ago

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
Sanofi announces negative CHMP opinion on Rezurock for chronic graft-vs-host disease in the EU but plans to seek re-examination. Rezurock has shown efficacy in clinical studies

EU Sanofi CHMP Rezurock CGVHD
BRIEF

published on 10/08/2025 at 07:05, 11 months 26 days ago

AlphaMedixTM: Positive Phase 2 Results for the Treatment of GEP-NETs

Clinical Trial Phase 2 Innovative Therapy AlphaMedixTM TNE-GEP
BRIEF

published on 09/24/2025 at 07:10, 1 year ago

Sanofi invests $625 million to boost Sanofi Ventures

Innovation Digital Health Investment Sanofi Biotechnologies
PRESS RELEASE

published on 09/24/2025 at 07:05, 1 year ago

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Sanofi commits $625 million to Sanofi Ventures to boost biotech and digital health investments. Focus on immunology, rare diseases, neurology, vaccines

Digital Health Investment Biotech Ventures Sanofi

Accesswire

Published on 10/03/2026 at 02:35, 18 hours 16 minutes ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day 3 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 1 day 7 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 7 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 7 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/03/2026 at 15:45, 5 hours 5 minutes ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 20 hours 55 minutes ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 1 hour ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 2 hours ago

EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)

Les Echos

Published on 10/02/2026 at 17:45, 1 day 3 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:30, 1 day 3 hours ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/01/2026 at 19:00, 2 days 1 hour ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 2 hours ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 2 hours ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE